Regeneron Pharmaceuticals (REGN)
Free Cash Flow Growth
-65.45%
Quarterly · Period ending:
REGN Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-65.45%period ending
Latest reported-65.45%period ending
REGN Quarterly Free Cash Flow YoY % (-1850.00% → -65.45%)
Year-over-year change
High-resolution chart · PNG
REGN free cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow Growth |
|---|---|
| -65.4506% | |
| 9.6562% | |
| -7.4111% | |
| 27.9614% | |
| 576.1705% | |
| -42.726% | |
| 28.2917% | |
| 18.0433% | |
| -84.2644% | |
| 13.5615% | |
| -50.488% | |
| 92.9071% | |
| 121.3729% | |
| -39.3132% | |
| -29.3065% | |
| -85.1725% | |
| -14.0945% | |
| 254.2842% | |
| 107.3298% | |
| 905.0061% | |
| -41.217% | |
| 4.7926% | |
| 64.9599% | |
| -193.5491% | |
| 768.1964% | |
| -35.8332% | |
| 0.7928% | |
| 25.6418% | |
| -66.8436% | |
| 52.5213% | |
| 40.061% | |
| -2.3872% | |
| 430.8397% | |
| 76.5977% | |
| 101.9576% | |
| -33.2963% | |
| -132.7699% | |
| 616.7752% | |
| 118.5844% | |
| -28.695% | |
| 1,353.133% | |
| 72.6225% | |
| 29.034% | |
| 783.189% | |
| -93.2447% | |
| -1,811.3679% | |
| -61.1978% | |
| 39.1482% | |
| 183.3595% | |
| -117.3649% | |
| 166.3381% | |
| 581.1085% | |
| 202.6981% | |
| 166.3075% | |
| 226.6484% | |
| 77.2976% | |
| -86.5499% | |
| -199.5664% | |
| 16.7047% | |
| -140.1491% | |
| -38.9365% | |
| -0.0061% | |
| -7.6266% | |
| 530.9582% | |
| 3.7009% | |
| -1.9554% | |
| -33.2299% | |
| 36.7988% | |
| -6,608.0734% | |
| -53.3422% | |
| -228.6701% | |
| -230.5223% | |
| 89.7825% | |
| -100.7092% | |
| -23.0502% | |
| 0.3625% | |
| 74.6181% | |
| -325.2807% | |
| 357.9216% | |
| 7.5745% | |
| 30.2314% | |
| -85.4216% | |
| -49.3272% | |
| -183.2881% | |
| -289.3212% | |
| 262.3805% | |
| 54.4794% | |
| -110.0986% | |
| 134.8231% | |
| -4.0189% | |
| 35.6798% | |
| 281.5989% | |
| -25.2756% | |
| 37.4093% | |
| -128.0883% | |
| -35.9878% | |
| -214.6407% | |
| -199.3426% | |
| -310.4154% | |
| -351.0582% |